Newbridge Financial Services Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17
Closed -$605 1458
2023
Q1
$605 Hold
17
﹤0.01% 1314
2022
Q4
$1K Buy
+17
New +$1.14K ﹤0.01% 1300

Other funds holding OMIC

Newbridge Financial Services Group's OMIC Position: Q2 2023 in Review

Newbridge Financial Services Group sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 17 shares — an estimated $605 sold.

Newbridge Financial Services Group first reported a position in OMIC in Q4 2022 and held it in 2 quarters. The position peaked at $1K in Q4 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Newbridge Financial Services Group reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 17 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $605.
  • Newbridge Financial Services Group first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Newbridge Financial Services Group's Singular Genomics Systems, Inc. Common Stock position peaked at $1K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Newbridge Financial Services Group's 13F filing for Q2 2023, filed 21 Jul 2023.